Barclays initiates CytomX Therapeutics stock with Overweight rating
Post Content
Business & Finance
Stay informed with expert takes on business strategy, investing, entrepreneurship, and global markets. CurioAtlas brings you articles that guide smarter decisions in finance and business growth.
Barclays initiates coverage on Arvinas stock with Overweight rating
Post Content
Barclays initiates Merus stock with Overweight rating, $112 price target
Post Content
‘It’s a circus over there’: Drama at the Fed has CEOs worrying about its reputation
In today’s CEO Daily: Diane Brady on the reputation of the Fed. The big story: Trump administration moves against political opponents. The markets: Global markets are mixed; U.S. futures are down. Plus: All the news and watercooler chat from Fortune.…
My mother’s lawyer stole her $400K estate. He was disbarred. How can we get our money back?
“Three years later, there is still no outcome and the investigation against this lawyer seems to have stalled.”
Chinese regulator tells local companies to stop buying Nvidia’s AI chips – FT
Post Content
Factbox-Global drugmakers rush to boost US presence as tariff threat looms
Post Content
French Socialists press Macron’s new government for major budget concessions
Post Content
UK house price growth slows to 2.8% in July, rental growth eases
Post Content
Colombia asks UN aviation agency for global standards to protect pets on planes
Post Content